DAL COLLO, GIADA
 Distribuzione geografica
Continente #
EU - Europa 526
NA - Nord America 507
AS - Asia 279
OC - Oceania 6
SA - Sud America 4
AF - Africa 3
Totale 1.325
Nazione #
US - Stati Uniti d'America 501
CN - Cina 199
GB - Regno Unito 144
IT - Italia 115
IE - Irlanda 58
DE - Germania 52
SE - Svezia 51
FR - Francia 36
RU - Federazione Russa 23
IN - India 20
VN - Vietnam 19
FI - Finlandia 17
SG - Singapore 13
KR - Corea 12
AT - Austria 7
NL - Olanda 7
AU - Australia 6
UA - Ucraina 5
BE - Belgio 4
CA - Canada 4
ID - Indonesia 4
IR - Iran 4
CO - Colombia 3
MY - Malesia 3
ES - Italia 2
JP - Giappone 2
PA - Panama 2
PL - Polonia 2
RO - Romania 2
CH - Svizzera 1
CL - Cile 1
EG - Egitto 1
KG - Kirghizistan 1
MA - Marocco 1
MU - Mauritius 1
PK - Pakistan 1
SA - Arabia Saudita 1
Totale 1.325
Città #
Southend 128
Chandler 123
Dublin 58
Beijing 54
Verona 38
New York 32
Ashburn 28
Ann Arbor 23
Woodbridge 23
Houston 21
Jinan 18
Lawrence 15
Nanjing 15
Princeton 15
Tianjin 15
Jacksonville 14
Omaha 14
Shenyang 14
Dong Ket 13
Wilmington 13
Redmond 12
Dearborn 11
Helsinki 11
Seoul 10
Hyderabad 7
Redwood City 7
Vienna 7
Haikou 6
Melbourne 6
Nanchang 6
Zhengzhou 6
Atlanta 5
Changsha 5
Hangzhou 5
Hebei 5
Jiaxing 5
Lancaster 5
Ningbo 5
Seattle 5
Singapore 5
Bologna 4
Brussels 4
Cagliari 4
Guangzhou 4
Kent 4
San Francisco 4
Sindelfingen 4
Tehran 4
Trento 4
Vancouver 4
Bareggio 3
Bogotá 3
Fuzhou 3
Los Angeles 3
Milan 3
Putian 3
Utrecht 3
Bandung 2
Boardman 2
Chennai 2
Chions 2
Clearwater 2
Fairfield 2
Falls Church 2
Genova 2
Illasi 2
Jakarta 2
Leipzig 2
Logroño 2
Luton 2
New Delhi 2
San Giovanni Lupatoto 2
Silea 2
Sprang 2
Taizhou 2
Timisoara 2
Tokyo 2
Venezia 2
Vicenza 2
Warsaw 2
Arco 1
Bengaluru 1
Berlin 1
Bishkek 1
Büdelsdorf 1
Cerea 1
Chengdu 1
Cheras 1
Chicago 1
Chongqing 1
Cologne 1
Düsseldorf 1
Esslingen am Neckar 1
Eugene 1
Frankfurt am Main 1
Guwahati 1
Henderson 1
Hendrik-Ido-Ambacht 1
Kuala Lumpur 1
Lahore 1
Totale 935
Nome #
THE PIVOTAL ROLE OF NOTCH SIGNALING IN B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL) CHEMOSENSITIVITY 131
Notch singalling inhibition as a multi-target therapy to overcome bone marrow microenvironment-mediated drug resistance in AML 130
Molecular characterization of msc-derived extracellular vesicles and correlation with their immunomodulatory potential 126
Role of GSK-3 signalling in non-promyelocitic acute myeloid leukemia (AML) cell response to chemotherapy 121
Inhibition of GSK-3 Signalling Enhances Sensitivity of Non-Promyelocitic Acute Myeloid Leukemia (AML) Cell to Chemotherapy 108
Role of Wnt/β-Catenin Signalling in Acute Myeloid Leukemia (AML) Cell Response to Chemotherapy 105
Rational of targeting WNT/beta-catenin signaling in acute myeloid leukemia (AML) 98
CHARACTERIZATION OF MESENCHYMAL STROMAL CELL-DERIVED EXTRACELLULAR VESICLES AND CORRELATION WITH THEIR IMMUNOSUPPRESSIVE PROPERTIES TOWARDS B CELLS 92
Extracellular Vesicles Mediate Mesenchymal Stromal Cell-Dependent Regulation of B Cell PI3K-AKT Signaling Pathway and Actin Cytoskeleton 88
Inhibition of Notch signaling enhances chemosensitivity in B cell precursor acute lymphoblastic leukemia 73
Characterization of a new B-ALL cell line with constitutional defect of the Notch signaling pathway 69
Notch Signaling Molecules as Prognostic Biomarkers for Acute Myeloid Leukemia 63
Small Molecule Inhibitors of Microenvironmental Wnt/β-Catenin Signaling Enhance the Chemosensitivity of Acute Myeloid Leukemia 59
Functional dosing of mesenchymal stromal cell-derived extracellular vesicles for the prevention of acute graft-versus-host-disease 53
Role of mesenchymal stromal cell-derived extracellular vesicles in tumour microenvironment 43
Totale 1.359
Categoria #
all - tutte 4.123
article - articoli 2.081
book - libri 0
conference - conferenze 1.760
curatela - curatele 0
other - altro 282
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.246


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020162 11 0 4 13 10 30 8 13 10 18 20 25
2020/2021166 22 16 10 25 20 24 5 0 2 3 16 23
2021/2022133 10 52 0 3 11 3 2 6 5 3 4 34
2022/2023346 17 43 25 54 25 97 0 22 45 2 12 4
2023/2024264 3 15 15 20 37 55 25 23 1 21 45 4
2024/202518 18 0 0 0 0 0 0 0 0 0 0 0
Totale 1.359